by Raymond Tel | Dec 14, 2022 | News
Alzheimer’s Disease (AD) is a complex and progressive neurodegenerative disease which is characterized by memory loss and cognitive impairment. It is one of the most prevalent neurodegenerative diseases and it is estimated that the number of patients will increase...
by Raymond Tel | Aug 1, 2022 | News
We at Sulfateq are very proud to have reached the finals out of more than twenty applications. The Innovation Award is awarded to the innovation with the most impact in the field of Life Sciences & Health. During the final on September 27, we will pitch our...
by Raymond Tel | Dec 14, 2020 | News
Groningen, The Netherlands & Ankara, Turkey – Sulfateq BV, an early stage biotech company developing a group of small molecules that maintain mitochondrial health, and GEN İlaç ve Sağlık Ürünleri Sanayi ve Ticaret A.Ş. (GEN), a leading speciality...
by Raymond Tel | Feb 25, 2020 | News
We are proud to announce that Sulfateq B.V. received a Samenwerkingsverband Noord-Nederland (SNN) Valorisation grant for the development of SUL-138 as Acute Kidney Injury (AKI) prophylaxis. This grant helps us to continue the development that was already stimulated by...
by Raymond Tel | Nov 1, 2019 | News
We are happy to share a new article about our product ROKEPIE which can be used to preserve cells and tissues during transport and storage. A direct comparison of HypoThermosol® and ROKEPIE was recently published in PlosONE. Freitas Robero from the group of Prof. Rui...